Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
202,731,676
-
Number of holders
-
117
-
Total 13F shares, excl. options
-
37,686,617
-
Shares change
-
-490,030
-
Total reported value, excl. options
-
$321,071,547
-
Value change
-
-$4,301,161
-
Put/Call ratio
-
7.8%
-
Number of buys
-
57
-
Number of sells
-
59
-
Price
-
$8.52
Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q4 2021
146 filings reported holding IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share as of 31 Dec 2021.
Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) had 117 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 37,686,617 shares of stock of the company.
Largest 10 holders included EVENTIDE ASSET MANAGEMENT, LLC, Deep Track Capital, LP, VANGUARD GROUP INC, BlackRock Inc., Alpine Global Management, LLC, STATE STREET CORP, EcoR1 Capital, LLC, Point72 Asset Management, L.P., TWO SIGMA INVESTMENTS, LP, and GEODE CAPITAL MANAGEMENT, LLC.
This table shows the top 117 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.